24 related articles for article (PubMed ID: 31771045)
1. Restoration of MARCKS enhances chemosensitivity in cancer.
Wenzel T; Büch T; Urban N; Weirauch U; Schierle K; Aigner A; Schaefer M; Kalwa H
J Cancer Res Clin Oncol; 2020 Apr; 146(4):843-858. PubMed ID: 32056006
[TBL] [Abstract][Full Text] [Related]
2.
Lu H; Zhao R; Qin Q; Tang L; Ma G; He B; Liang J; Wei L; Wang X; Bie Q; Wang X; Zhang B
Int J Gen Med; 2023; 16():1603-1619. PubMed ID: 37152272
[TBL] [Abstract][Full Text] [Related]
3. The Role of MARCKS in Metastasis and Treatment Resistance of Solid Tumors.
Chiu CL; Zhao H; Chen CH; Wu R; Brooks JD
Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230850
[TBL] [Abstract][Full Text] [Related]
4. A plasma-derived extracellular vesicle mRNA classifier for the detection of breast cancer.
Cai GX; Lin L; Zhai XM; Guo ZW; Wu YS; Ye GL; Liu Q; Chen LS; Xing GY; Zhao QH; Tang LL; Mai SH; Ye BJ
Gland Surg; 2021 Jun; 10(6):2002-2009. PubMed ID: 34268084
[TBL] [Abstract][Full Text] [Related]
5. Pathophysiological roles of myristoylated alanine-rich C-kinase substrate (MARCKS) in hematological malignancies.
Iyer DN; Faruq O; Zhang L; Rastgoo N; Liu A; Chang H
Biomark Res; 2021 May; 9(1):34. PubMed ID: 33958003
[TBL] [Abstract][Full Text] [Related]
6. Identification of novel candidate genes by exome sequencing in Tunisian familial male breast cancer patients.
Ben Kridis-Rejeb W; Ben Ayed-Guerfali D; Ammous-Boukhris N; Ayadi W; Kifagi C; Charfi S; Saguem I; Sellami-Boudawara T; Daoud J; Khanfir A; Mokdad-Gargouri R
Mol Biol Rep; 2020 Sep; 47(9):6507-6516. PubMed ID: 32901360
[TBL] [Abstract][Full Text] [Related]
7. Myristoylated alanine-rich C kinase substrate (MARCKS): a multirole signaling protein in cancers.
Fong LWR; Yang DC; Chen CH
Cancer Metastasis Rev; 2017 Dec; 36(4):737-747. PubMed ID: 29039083
[TBL] [Abstract][Full Text] [Related]
8. MARCKS and Lung Disease.
Sheats MK; Yin Q; Fang S; Park J; Crews AL; Parikh I; Dickson B; Adler KB
Am J Respir Cell Mol Biol; 2019 Jan; 60(1):16-27. PubMed ID: 30339463
[TBL] [Abstract][Full Text] [Related]
9. Stromal Expression of MARCKS Protein in Ovarian Carcinomas Has Unfavorable Prognostic Value.
Doghri R; Manai M; Finetti P; Driss M; Agavnian E; Lopez M; Elghardallou M; Charafe-Jauffret E; Manai M; Chaffanet M; Birnbaum D; Mrad K; Bertucci F
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29295532
[TBL] [Abstract][Full Text] [Related]
10. MARCKS protein overexpression in inflammatory breast cancer.
Manai M; Thomassin-Piana J; Gamoudi A; Finetti P; Lopez M; Eghozzi R; Ayadi S; Lamine OB; Manai M; Rahal K; Charafe-Jauffret E; Jacquemier J; Viens P; Birnbaum D; Boussen H; Chaffanet M; Bertucci F
Oncotarget; 2017 Jan; 8(4):6246-6257. PubMed ID: 28009981
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of Upregulation of Myristoylated Alanine-Rich C-Kinase Substrate in Gastric Cancer.
Quan R; Ning Z; Wang Y; Yu W; Zhu H
Med Sci Monit; 2019 Jan; 25():279-287. PubMed ID: 30623893
[TBL] [Abstract][Full Text] [Related]
12. MARCKS as a Potential Therapeutic Target in Inflammatory Breast Cancer.
Manai M; ELBini-Dhouib I; Finetti P; Bichiou H; Reduzzi C; Aissaoui D; Ben-Hamida N; Agavnian E; Srairi-Abid N; Lopez M; Amri F; Guizani-Tabbane L; Rahal K; Mrad K; Manai M; Birnbaum D; Mamessier E; Cristofanilli M; Boussen H; Kharrat M; Doghri R; Bertucci F
Cells; 2022 Sep; 11(18):. PubMed ID: 36139501
[TBL] [Abstract][Full Text] [Related]
13. Myristoylated alanine rich protein kinase C substrate is a potential cancer prognostic factor that regulates cell migration and invasion in glioblastoma.
Xiang W; Peng T; Ming Y; Li S; Wang K; Wang H; Chen L; Zhou J
Oncol Rep; 2019 Apr; 41(4):2464-2470. PubMed ID: 30816497
[TBL] [Abstract][Full Text] [Related]
14. MARCKS protein overexpression is associated with poor prognosis in male breast cancer.
Manai M; Abdeljaoued S; Goucha A; Adouni O; Bettaieb I; Bouzaien H; Rahal K; Birnbaum D; Bertucci F; Gamoudi A
Cancer Biomark; 2019; 26(4):513-522. PubMed ID: 31771045
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
